1. Home
  2. ATXI vs MULN Comparison

ATXI vs MULN Comparison

Compare ATXI & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXI
  • MULN
  • Stock Information
  • Founded
  • ATXI 2015
  • MULN 2014
  • Country
  • ATXI United States
  • MULN United States
  • Employees
  • ATXI N/A
  • MULN N/A
  • Industry
  • ATXI Biotechnology: Pharmaceutical Preparations
  • MULN Auto Manufacturing
  • Sector
  • ATXI Health Care
  • MULN Consumer Discretionary
  • Exchange
  • ATXI Nasdaq
  • MULN Nasdaq
  • Market Cap
  • ATXI 3.0M
  • MULN 3.5M
  • IPO Year
  • ATXI 2017
  • MULN N/A
  • Fundamental
  • Price
  • ATXI $1.85
  • MULN $0.48
  • Analyst Decision
  • ATXI
  • MULN
  • Analyst Count
  • ATXI 0
  • MULN 0
  • Target Price
  • ATXI N/A
  • MULN N/A
  • AVG Volume (30 Days)
  • ATXI 61.4K
  • MULN 10.5M
  • Earning Date
  • ATXI 11-14-2024
  • MULN 02-11-2025
  • Dividend Yield
  • ATXI N/A
  • MULN N/A
  • EPS Growth
  • ATXI N/A
  • MULN N/A
  • EPS
  • ATXI N/A
  • MULN N/A
  • Revenue
  • ATXI N/A
  • MULN $156,570.00
  • Revenue This Year
  • ATXI N/A
  • MULN N/A
  • Revenue Next Year
  • ATXI N/A
  • MULN N/A
  • P/E Ratio
  • ATXI N/A
  • MULN N/A
  • Revenue Growth
  • ATXI N/A
  • MULN N/A
  • 52 Week Low
  • ATXI $1.60
  • MULN $0.36
  • 52 Week High
  • ATXI $15.00
  • MULN $987.00
  • Technical
  • Relative Strength Index (RSI)
  • ATXI 47.67
  • MULN 25.48
  • Support Level
  • ATXI $1.72
  • MULN $0.36
  • Resistance Level
  • ATXI $2.04
  • MULN $0.54
  • Average True Range (ATR)
  • ATXI 0.19
  • MULN 0.17
  • MACD
  • ATXI -0.00
  • MULN 0.02
  • Stochastic Oscillator
  • ATXI 33.39
  • MULN 10.82

About ATXI Avenue Therapeutics Inc.

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

About MULN Mullen Automotive Inc.

Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.

Share on Social Networks: